hero-bg
Drive your

Healthcare breakthroughs

with our formidable R&D prowess and an extensive range of high-quality APIs and Intermediates.

Discover our product portfolio

APIs | CEP/EDMP approved

  • Eltrombopog Olamine

    Thrombopoietin Receptor Agonists

    • Filing status

      Ready to be filed in Key Markets

    • Capacity

      20 MT Annually

  • Bilastine

    Anti Histamine

    • Filing status

      ASMF, USDMF

    • Capacity

      24 MT Annually

  • Amlodipine Besylate

    Anti-Hypertensive

    • Filing status

      CEP/EDMF, MFDS, NMPA, USDMF

    • Capacity

      180 MT Annually

  • Acyclovir

    Antiviral

    • Filing status

      CEP/EDMF, TDMF, USDMF

    • Capacity

      30 MT Annually

APIs | USDMF approved

  • Amlodipine Besylate

    Anti-Hypertensive

    • Filing status

      CEP/EDMF, MFDS, NMPA, USDMF

    • Capacity

      180 MT Annually

  • Acyclovir

    Antiviral

    • Filing status

      CEP/EDMF, TDMF, USDMF

    • Capacity

      30 MT Annually

R&D

At the heart of our operation lies a dynamic R&D nucleus. Our accomplished team, comprising leading scientists and experienced chemists, propels advanced research and innovation. Boasting a formidable cadre of 60 R&D scientists, alongside 65 analytical experts, we forge a pathway to progress. Backed by 10 doctorates, our technical acumen fuels pioneering discoveries, underpinned by state-of-the-art infrastructure.

Manufacturing Units

Global expertise, Strategic execution and Scalable capacity.

  • ISO 90001:2015 certification

  • USFDA approved

  • Cryogenic capability

  • Hydrogenation capability

Accreditations

We manufacture a diverse and differentiated product portfolio of APIs by developing innovative and cost-efficient manufacturing processes in full compliance with environmental, health and safety, and international GMP standards.